Tukenmez Tigen, E. Et Al. 2023. The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.17, no.11 , 1549-1555.

Tukenmez Tigen, E., Erturk Sengel, B., Ozben, B., Perk Gurun, H., Balcan, B., Bilgili, B., ... Gul, F.(2023). The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.17, no.11, 1549-1555.

Tukenmez Tigen, Elif Et Al. "The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey," JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.17, no.11, 1549-1555, 2023

Tukenmez Tigen, Elif T. Et Al. "The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey." JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.17, no.11, pp.1549-1555, 2023

Tukenmez Tigen, E. Et Al. (2023) . "The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey." JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.17, no.11, pp.1549-1555.

@article{article, author={Elif Tukenmez Tigen Et Al. }, title={The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey}, journal={JOURNAL OF INFECTION IN DEVELOPING COUNTRIES}, year=2023, pages={1549-1555} }